DeepSense Biotechnologies has completed a production-ready public website architecture designed to support scientific credibility, professional collaboration, industry licensing and a future limited-access membership program.
One platform, distinct audiences
The experience separates healthcare-professional, industry-partner, consumer-member and investor pathways. Each path has a different conversion, verification process and access level.
Evidence at the centre
A searchable Evidence Centre distinguishes foundational, mechanistic, preclinical, human, platform and quality records. Public summaries are substantive; more detailed materials are staged for verified professional or qualified partner access.
Three commercial pathways
The partner environment is organized around dietary supplements, cosmetics and pharmaceuticals, with delivery technology, applications, evidence and commercial model connected across each pathway.
Provenance without romanticization
The source narrative distinguishes historical chenpi context from modern Bhutanese provenance, traceability and controlled supply.
Security boundary
The public site and secure form endpoint are ready for Hostinger deployment. Confidential portals are represented as noindex access shells and must be connected to server-side identity, authorization and protected document storage before use.